WALL, N.J., Dec. 23 /PRNewswire-FirstCall/ --
Dear Shareholder:
Thank you for your continued
support of BIO-key.
As we conclude what we
believe will be a very
strong year, we want to take
the opportunity to provide
you with a preliminary
business update for 2008 and
business outlook for 2009.
2008 has been an important
turnaround year in BIO-key's
history. Revenue is
currently projected to grow
more than 20% over 2007 and
we expect to achieve
profitability in the fourth
quarter and cumulatively for
the last nine months of the
year.
We see this positive
performance continuing into
2009. This optimism is
grounded on our growing
pipeline of marquee
customers:
-- We announced earlier this
year a major contract with
Sagem Morpho, where we are
'fusing' our BIO-key
matching algorithm with
Sagem's to create the most
accurate, high performance
solution for finger
identification in the
industry. This fused
offering will be utilized in
a number of government
programs including the
upcoming FBI's NGI IAFIS
opportunity. Equally
important to BIO-key and our
partnership is Sagem's
position as the world's
leading fingerprint-matching
provider. Together we will
be well positioned to
compete for large scale
identification opportunities
around the globe.
-- As a result of the
successful completion of the
Bangladesh voter
registration project, our
customer, Major General
Shafiqul Islam was presented
with the Outstanding
Achievement Award by the
ID World
International Congress
held in
Milan, Italy on
November 18, 2008. The
General won the award in
recognition of his
leadership during the
Bangladesh
government's successful
completion of its Voter
Registration Project in
preparation for the December
29 general elections.
Senator
John McCain in his
recent visit to
Bangladesh on
Wednesday, December 3, told
reporters at a press
conference in Dhaka's
Zia
International Airport,
"It seems to me that with
the incredible registering
of 80 million people, this
has the possibility of being
the fairest election,
perhaps in the entire
world."
-- McKesson has deployed
BIO-key's biometric
technology in their new
automated medication
dispensing cabinets. "The
Connect-Rx integrated
software platform surpasses
all industry functionality
on the market today," said
Dave Souerwine, president of
McKesson's
Automation Solutions Group.
"It's viewed by industry
experts as at least two
generations ahead of
competing software
solutions. Connect-Rx
provides the foundation that
hospitals need to deliver
safe, cost-effective care,
and enables hospitals to
maximize their investment
while improving safety and
workforce productivity."
-- Perhaps the leading
technologist in the medical
industry, Dr.
John
Halamka, Dean at the
Harvard
Medical School and IT
Director at
Beth
Israel Hospital said
in his December blog, "my
cool technology of the week
is the Bio-key fingerprint
biometrics authentication
system, an authentication
solution that is my favorite
candidate for two factor
authentication, such as will
likely be required by the
Drug
Enforcement Agency
for e-prescribing of
controlled substances.
Simple to implement,
standards-based, and easy to
use biometric authentication
-- that's cool!"
-- Other recent orders were
received from
AT&T,
BNP Paribas Financial
Services, Brand New
Technologies in
South
Africa, ChoicePoint,
Pulaski County (IN)
Sheriff's Office,
Bexley
(OH) Police Department
and Hawaii
County (HI) Police
Department.
We believe these new awards
along with our recurring
maintenance revenue will
enable us to grow and be
profitable throughout 2009.
Our overall plan is to fully
develop our high margin
strategic businesses and
opportunistically exploit
certain assets to generate
sufficient cash to fully
redeem our preferred stock.
We believe that market
conditions will improve in
the second half of 2009 and
that, when combined with our
anticipated solid operating
results will offer the
company additional
flexibility.
We also believe that we will
generate sufficient cash
such that under certain
conditions the 2009
preferred dividends could be
paid in cash and thus would
have the potential to
eliminate the dilutive and
selling pressure effect on
the stock coming from the
payment of millions of
shares of stock to service
the preferred dividends.
We believe our solid 2008
performance marked with
growth, profitability, solid
sales pipeline and high
quality large footprint
partners as customers and
references makes us well
prepared for continued
strong results in 2009.
All of BIO-key wishes you a Merry Christmas, Happy Holidays and a
prosperous New Year.
Sincerely,
Michael DePasquale
CEO
BIO-key International
BIO-key Safe Harbor
Statement
Certain statements contained
in this letter to
shareholders may be
construed as
"forward-looking statements"
as defined in the Private
Securities Litigation Reform
Act of 1995 (the "Act"). The
words "estimate," "project,"
"intends," "expects,"
"anticipates," "believes"
and similar expressions are
intended to identify
forward-looking statements.
Such forward-looking
statements are made based on
management's beliefs, as
well as assumptions made by,
and information currently
available to, management
pursuant to the
"safe-harbor" provisions of
the Act. These statements
are subject to certain risks
and uncertainties that may
cause actual results to
differ materially from those
projected on the basis of
these statements. These
risks and uncertainties
include, without limitation,
our history of losses and
limited revenue, our ability
to develop new products and
evolve existing ones, the
impact on our business of
the recent financial crisis
in the global capital
markets and negative global
economic trends, and our
ability to attract and
retain key personnel. For a
more complete description of
these and other risk factors
that may affect the future
performance of
BIO-key
International, Inc.
(OTC Bulletin Board: BKYI),
see "Risk Factors" in the
Company's Annual Report on
Form 10-KSB for the year
ended December 31, 2007 and
its other filings with the
Securities
and Exchange Commission.
Readers are cautioned not to
place undue reliance on
these forward-looking
statements, which speak only
as of the date made. The
Company also undertakes no
obligation to disclose any
revision to these
forward-looking statements
to reflect events or
circumstances after the date
made or to reflect the
occurrence of unanticipated
events.